Selective expansion of neoantigen-specific peripheral blood lymphocytes through antigen-presenting cell-T cell conjugate isolation.

IF 11.7 1区医学 Q1 IMMUNOLOGY

Journal for Immunotherapy of Cancer Pub Date : 2026-10-15 DOI:10.1136/jitc-2026-014996

Mamduh Khateb, Raina Jung, Patrick Hadley, Stav Leibou, Zhiya Yu, Aaron J Dinerman, Victoria Dulemba, Billel Gasmi, Noam Levin, Sanghyun Peter Kim, Aarushi Bhasin, Deepali Bhat, Sivasish Sindiri, Jared J Gartner, Todd D Prickett, Tiffany Benzine, Shahram Farid, Maria Parkhurst, Hyunmi Halas, Guangzhe Ge, Yaqiang Cao, Keji Zhao, James C Yang, Paul Robbins, Frank J Lowery, Sri Krishna, Theo Heller, Daniel Mcvicar, Steven A Rosenberg, Nicholas D Klemen

引用次数: 0

查看原文本刊更多论文

通过抗原呈递细胞- t细胞偶联分离选择性扩增新抗原特异性外周血淋巴细胞。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal for Immunotherapy of Cancer Biochemistry, Genetics and Molecular Biology-Molecular Medicine

CiteScore

17.70

自引率

4.60%

发文量

522

审稿时长

18 weeks

期刊介绍： The Journal for ImmunoTherapy of Cancer (JITC) is a peer-reviewed publication that promotes scientific exchange and deepens knowledge in the constantly evolving fields of tumor immunology and cancer immunotherapy. With an open access format, JITC encourages widespread access to its findings. The journal covers a wide range of topics, spanning from basic science to translational and clinical research. Key areas of interest include tumor-host interactions, the intricate tumor microenvironment, animal models, the identification of predictive and prognostic immune biomarkers, groundbreaking pharmaceutical and cellular therapies, innovative vaccines, combination immune-based treatments, and the study of immune-related toxicity.